Hormone für die Schilddrüsenfunktion Archives

runover: array(10) { ["class"]=> string(12) "amf-run-over" ["id"]=> string(10) "oewgk_2024" ["type"]=> string(5) "image" ["path"]=> string(90) "https://www.gesundheitswirtschaft.at/app/uploads/2024/02/O╠eGWK-2024_Banner-728x90px.jpg" ["url"]=> string(21) "https://www.oegwk.at/" ["end"]=> string(12) "202406150000" ["now"]=> string(12) "202404190039" ["not_expired"]=> bool(true) ["type_mobile"]=> string(5) "image" ["path_mobile"]=> string(91) "https://www.gesundheitswirtschaft.at/app/uploads/2024/02/O╠eGWK-2024_Banner-300x250px.jpg" }

Hormone für die Schilddrüsenfunktion

The IASON Group of companies produce radiopharmaceuticals for positron-emission-tomography and deliver specialized laboratory products for the target groups nuclear medicine and laboratory. Innovative products compliant with the latest quality standards convince customers from all across Europe.
Our motto: we acquire future-orientated products on the world market and introduce those on the Central European market.
The IASON Group is the only company world-wide which has obtained Marketing Authorizations for four different radiopharmaceuticals for positron-emission-tomography, which renders IASON Group number one in terms of innovation and development.